Skip to main content
. 2023 Jan 11;12(1):33–57. doi: 10.21037/tau-22-663

Figure 4.

Figure 4

Analysis of upstream miRNAs of SLC7A11 in RCC. (A) The miRSystem platform was used to predict the upstream miRNAs of SLC7A11; (B) the expression of miR-26a-5p in KICH and normal tissues; (C) the expression of miR-26b-5p in KICH and normal tissues; (D) the expression of miR-27a-3p in KICH and normal tissues; (E) the expression of miR-27b-3p in KICH and normal tissues; (F) the expression of miR-32-5p in KICH and normal tissues; (G) the expression of miR-363-3p in KICH and normal tissues; (H) the expression of miR-26a-5p in KIRC and normal tissues; (I) the expression of miR-26b-5p in KIRC and normal tissues; (J) the expression of miR-27b-3p in KIRC and normal tissues; (K) the expression of miR-363-3p in KIRC and normal tissues; (L) the expression of miR-26a-5p in KIRP and normal tissues. Differential expressions from the starBase database in (B-L). **P<0.01; ***P<0.001. RCC, renal cell carcinoma; KIRP, kidney renal papillary cell carcinoma; KICH, kidney chromophobe cell carcinoma; KIRC, kidney renal clear cell carcinoma.